Biomea Fusion, Inc. (BMEA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
12/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBMEA / S&P -3.92% / 15.20% |
LoseBMEA / S&P BMEA unavailable / 15.00% |
LoseBMEA / S&P -90.40% / 50.40% |
| 2026-Q11/3 |
WinBMEA / S&P 23.39% / -4.33% |
LoseBMEA / S&P BMEA unavailable / 11.30% |
LoseBMEA / S&P -80.79% / 27.70% |
| 2025-Q40/3 |
LoseBMEA / S&P -38.61% / 2.65% |
LoseBMEA / S&P BMEA unavailable / 9.00% |
LoseBMEA / S&P -65.80% / 13.40% |
| 2025-Q31/3 |
WinBMEA / S&P 12.22% / 8.12% |
LoseBMEA / S&P BMEA unavailable / 4.61% |
LoseBMEA / S&P -40.65% / 13.45% |
| 2025-Q20/3 |
LoseBMEA / S&P -15.49% / 10.94% |
LoseBMEA / S&P BMEA unavailable / 4.83% |
LoseBMEA / S&P -22.56% / 10.63% |
| 2025-Q10/3 |
LoseBMEA / S&P -45.10% / -4.27% |
LoseBMEA / S&P BMEA unavailable / 4.98% |
LoseBMEA / S&P -0.84% / 10.57% |
| 2024-Q41/3 |
LoseBMEA / S&P -61.58% / 2.41% |
LoseBMEA / S&P BMEA unavailable / 5.25% |
WinBMEA / S&P 10.69% / 6.15% |
| 2024-Q32/3 |
WinBMEA / S&P 124.44% / 5.89% |
LoseBMEA / S&P BMEA unavailable / 5.89% |
WinBMEA / S&P 19.70% / 6.11% |
| 2024-Q21/3 |
LoseBMEA / S&P -69.90% / 4.28% |
LoseBMEA / S&P BMEA unavailable / 5.38% |
WinBMEA / S&P 17.12% / 5.12% |
| 2024-Q11/3 |
LoseBMEA / S&P 2.96% / 10.56% |
LoseBMEA / S&P BMEA unavailable / 5.71% |
WinBMEA / S&P 10.87% / 5.59% |
| 2023-Q41/3 |
LoseBMEA / S&P 5.52% / 11.69% |
LoseBMEA / S&P BMEA unavailable / 6.81% |
WinBMEA / S&P 23.57% / 7.78% |
| 2023-Q31/3 |
LoseBMEA / S&P -37.31% / -3.27% |
LoseBMEA / S&P BMEA unavailable / 7.52% |
WinBMEA / S&P 36.18% / -5.03% |
| 2023-Q21/3 |
LoseBMEA / S&P -29.22% / 8.74% |
LoseBMEA / S&P BMEA unavailable / 9.50% |
WinBMEA / S&P 57.82% / -8.57% |
| 2023-Q11/3 |
WinBMEA / S&P 267.85% / 7.50% |
LoseBMEA / S&P BMEA unavailable / 10.77% |
LoseBMEA / S&P BMEA unavailable / -15.69% |
| 2022-Q40/3 |
LoseBMEA / S&P -13.80% / 7.56% |
LoseBMEA / S&P BMEA unavailable / 11.88% |
LoseBMEA / S&P BMEA unavailable / -17.99% |
| 2022-Q30/3 |
LoseBMEA / S&P -18.36% / -4.88% |
LoseBMEA / S&P BMEA unavailable / 13.47% |
LoseBMEA / S&P BMEA unavailable / -1.41% |
| 2022-Q21/3 |
WinBMEA / S&P 168.61% / -16.10% |
LoseBMEA / S&P BMEA unavailable / 13.71% |
LoseBMEA / S&P BMEA unavailable / 11.04% |
| 2022-Q10/3 |
LoseBMEA / S&P -40.13% / -4.60% |
LoseBMEA / S&P BMEA unavailable / 15.97% |
LoseBMEA / S&P BMEA unavailable / 42.23% |
| 2021-Q40/3 |
LoseBMEA / S&P -37.76% / 11.03% |
LoseBMEA / S&P BMEA unavailable / 15.00% |
LoseBMEA / S&P BMEA unavailable / 96.40% |
| 2021-Q30/3 |
LoseBMEA / S&P -23.32% / 0.58% |
LoseBMEA / S&P BMEA unavailable / 10.77% |
LoseBMEA / S&P BMEA unavailable / 69.42% |
| 2021-Q20/3 |
LoseBMEA / S&P BMEA unavailable / 8.55% |
LoseBMEA / S&P BMEA unavailable / 6.58% |
LoseBMEA / S&P BMEA unavailable / 51.81% |
| 2021-Q10/3 |
LoseBMEA / S&P BMEA unavailable / 6.17% |
LoseBMEA / S&P BMEA unavailable / -1.06% |
LoseBMEA / S&P BMEA unavailable / 7.39% |
| 2020-Q40/3 |
LoseBMEA / S&P BMEA unavailable / 12.15% |
LoseBMEA / S&P BMEA unavailable / -3.72% |
LoseBMEA / S&P BMEA unavailable / -33.42% |
| 2020-Q30/3 |
LoseBMEA / S&P BMEA unavailable / 8.93% |
LoseBMEA / S&P BMEA unavailable / -2.04% |
LoseBMEA / S&P BMEA unavailable / -27.10% |
| 2020-Q20/3 |
LoseBMEA / S&P BMEA unavailable / 20.54% |
LoseBMEA / S&P BMEA unavailable / -0.46% |
LoseBMEA / S&P BMEA unavailable / -27.11% |
| 2020-Q10/3 |
LoseBMEA / S&P BMEA unavailable / -19.60% |
LoseBMEA / S&P BMEA unavailable / 3.47% |
LoseBMEA / S&P BMEA unavailable / -14.75% |
| 2019-Q40/3 |
LoseBMEA / S&P BMEA unavailable / 9.07% |
LoseBMEA / S&P BMEA unavailable / 5.36% |
LoseBMEA / S&P BMEA unavailable / 2.99% |
| 2019-Q30/3 |
LoseBMEA / S&P BMEA unavailable / 1.70% |
LoseBMEA / S&P BMEA unavailable / 5.02% |
LoseBMEA / S&P BMEA unavailable / 0.21% |
| 2019-Q20/3 |
LoseBMEA / S&P BMEA unavailable / 4.30% |
LoseBMEA / S&P BMEA unavailable / 6.64% |
LoseBMEA / S&P BMEA unavailable / 8.65% |
| 2019-Q10/3 |
LoseBMEA / S&P BMEA unavailable / 13.65% |
LoseBMEA / S&P BMEA unavailable / 8.12% |
LoseBMEA / S&P BMEA unavailable / 14.29% |
| 2018-Q40/3 |
LoseBMEA / S&P BMEA unavailable / -13.52% |
LoseBMEA / S&P BMEA unavailable / 9.05% |
LoseBMEA / S&P BMEA unavailable / 18.23% |
| 2018-Q30/3 |
LoseBMEA / S&P BMEA unavailable / 7.71% |
LoseBMEA / S&P BMEA unavailable / 10.21% |
LoseBMEA / S&P BMEA unavailable / 19.06% |
| 2018-Q20/3 |
LoseBMEA / S&P BMEA unavailable / 3.43% |
LoseBMEA / S&P BMEA unavailable / 9.03% |
LoseBMEA / S&P BMEA unavailable / 14.46% |
| 2018-Q10/3 |
LoseBMEA / S&P BMEA unavailable / -0.76% |
LoseBMEA / S&P BMEA unavailable / 7.68% |
LoseBMEA / S&P BMEA unavailable / 12.46% |
| 2017-Q40/3 |
LoseBMEA / S&P BMEA unavailable / 6.64% |
LoseBMEA / S&P BMEA unavailable / 7.03% |
LoseBMEA / S&P BMEA unavailable / 13.82% |
| 2017-Q30/3 |
LoseBMEA / S&P BMEA unavailable / 4.48% |
LoseBMEA / S&P BMEA unavailable / 5.68% |
LoseBMEA / S&P BMEA unavailable / 17.57% |
| 2017-Q20/3 |
LoseBMEA / S&P BMEA unavailable / 3.09% |
LoseBMEA / S&P BMEA unavailable / 4.83% |
LoseBMEA / S&P BMEA unavailable / 17.74% |
| 2017-Q10/3 |
LoseBMEA / S&P BMEA unavailable / 6.07% |
LoseBMEA / S&P BMEA unavailable / 3.67% |
LoseBMEA / S&P BMEA unavailable / 13.32% |
| 2016-Q40/3 |
LoseBMEA / S&P BMEA unavailable / 3.82% |
LoseBMEA / S&P BMEA unavailable / 2.09% |
LoseBMEA / S&P BMEA unavailable / 7.05% |
| 2016-Q30/3 |
LoseBMEA / S&P BMEA unavailable / 3.85% |
LoseBMEA / S&P BMEA unavailable / 0.20% |
LoseBMEA / S&P BMEA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BMEA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -13.85% | 20.78% |
| Annualized return | -13.85% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BMEA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.48% | 83.14% |
| Annualized return | -35.09% | 12.86% |
10Y · 2021-04-16 to 2026-08-27
| Metric | BMEA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.97% | 319.30% |
| Annualized return | -21.37% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |